Search

Search Results
Results 21 - 30 of 88 for multiple sclerosis
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Trazent intended for persons living in Australia.
  • Drug - 22 Mar 2022
    Consumer Medicine Information (CMI) about Vumerity intended for persons living in Australia.
  • Drug - 6 Aug 2020
    Consumer Medicine Information (CMI) about Synacthen Depot (tetracosactide) intended for persons living in Australia.
  • Drug - 7 Jun 2024
    Consumer Medicine Information (CMI) about Fynod intended for persons living in Australia.
  • Drug - 18 Mar 2024
    Consumer Medicine Information (CMI) about Certican intended for persons living in Australia.
  • Drug - 13 Dec 2022
    Consumer Medicine Information (CMI) about Actemra PFP AI intended for persons living in Australia.
  • Drug - 24 Nov 2022
    Consumer Medicine Information (CMI) about Actemra PFS intended for persons living in Australia.
  • Drug - 16 Nov 2020
    Consumer Medicine Information (CMI) about Loette (New Formulation) (Levonorgestrel and Ethinylestradiol Tablets) intended for persons living in Australia.
  • Drug - 13 Dec 2019
    Consumer Medicine Information (CMI) about Loette (Levonorgestrel and Ethinylestradiol Tablets) intended for persons living in Australia.
  • Drug - 9 May 2025
    Consumer Medicine Information (CMI) about Remicade intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.